If your dog or cat is missing a leg, osteoarthritis will probably become an issue at some point in time. If and when it does, you may want to look into Galliprant®, a new tool for managing arthritis in Tripawd dogs. Just months after its release, initial feedback from veterinary pain management experts and other Tripawd families indicate that it’s worth looking into.
A New Tool for Managing Arthritis in Tripawd Dogs
Whether you’re a dog, cat or human, osteoarthritis works the same way. This painful swelling of the joints leads to decreased mobility and poor quality of life. People and pets with osteoarthris don’t enjoy moving around as much, and as a result they gain weight. The excess pounds cause even more joint swelling and the vicious cycle continues.
As Tripawd pet parents we have many tools for managing arthritis in Tripawd dogs such as:
- Weight control
- Appropriate Tripawd exercise
- Chiropractic care
- Conventional NSAIDs (Non-steroidal anti-inflammatory drugs like Rimadyl)
During our week at #WVC2017 we heard about a new tool to manage canine osteoarthritis, called Galliprant®. In his learning session called “Updates in Pain Management: New Tools in the Toolbox and What’s in the Pipeline,” renowned veterinary pain management expert Dr. Mark Epstein, DVM DABVP CVPP shared his excitement over this new canine osteoarthritis remedy. After the talk we discovered at the Galliprant website that:
Galliprant® (grapiprant tablets) is a new class of anti-inflammatory that targets pain, so you can start targeted pain relief from the earliest diagnosed stages of canine OA.
- Galliprant is NOT a NSAID. It’s a “first-in-class piprant; a non-COX-inhibiting prostaglandin receptor antagonist (PRA)”
- Galliprant “blocks the EP4 receptor, the primary mediator of canine OA pain and inflammation”
In a nutshell, here’s why Galliprant is such a huge breakthrough: it lacks the potential side effects caused by long term use of NSAIDs, such as gastrointestinal upset and organ damage. Galliprant’s remarkable study results show it’s the biggest canine osteoarthritis drug breakthrough in years:
- Studied at up to approximately 15X the labeled 2 mg/kg dose for a 9-month duration in healthy dogs
- No clinically significant changes in liver, kidney or coagulation parameters
- No noticeable effects on food consumption, body weight, ECG, organ weight or hematology
- In most situations, gastrointestinal disturbances were mild or slight and fairly infrequent
- Neither treatment nor GI disturbance was associated with changes in appetite, appearance or demeanor of dogs
- Suitable for dogs as young as 9 months of age
In the nine month study, not one dog was eliminated because of serious gastrointestinal issues. All 287 dogs completed the study successfully.
Galliprant Gives Tripawd Austin His Sparkle Back
Before Dr. Epstein’s WVC talk was even over, we texted our Tripawd friends, the Oaktown Pack about it. Their four dogs always experienced gastrointestinal blowouts with NSAIDs. Being the great advocates that they are, Oaktown Pack’s leaders Martha and Ralph had already started using it on three of their four dogs with osteoarthritis.
“Out of three dogs that we tried it on, it worked on one,” says Austin’s mom, Martha. The lucky dog is Austin, a 68-pound, eight year old rear leg Tripawd. Before he started Galliprant, Austin had signs of osteoarthritis, despite his humans’ vigilant weight management and exercise moderation. His sensitive belly always had trouble with NSAIDs. Just over a month after starting Galliprant, he clearly got his sparkle back.
“It’s working great. Austin is a new dog. He’s been walking more, he’s perky! He seems to be much happier,” says Martha.
The other dogs didn’t indicate they were benefiting from Galliprant, so at $110 per month, per dog, Martha stopped treatment for them. Austin is now the only Oaktown Pack member enjoying a new leash on life because of Galliprant.
Got a Tripawd with Osteoarthritis? Talk to Your Vet about Galliprant
Our intention isn’t to sound like a pharmaceutical infomercial and we aren’t making any revenue off its sale. We’re just so excited that this new non-NSAID drug comes with far less risk for dogs. Galliprant is currently being studied in cats and we hope they can benefit from it soon. There’s no guarantee it will work for every dog, but if you give it a try, let us know how it works for your Tripawd.
10 thoughts on “Managing Arthritis in Tripawd Dogs with Galliprant”
My min pin Tripawd has been on Galliprant for just over a month. While his pain is decreased, his appetite is also decreased and he sometimes feels poor enough to refuse his other meds. I also hear occasional sounds of gastric distress. Will take him for a follow-up this week to see if it’s the Galliprant and if so, what other alternatives are available.
Sorry to hear about your pup, Susan. Let us know what the vet recommends, please visit our Hopping Around Forum to tell us more!
My golden retriever Buddy will be 17 in April. He has been a tripawd since he was a few days old. He had been on Rimadyl for some time.
He has now been on galliprant for just over a month. He is sleeping less, moving more and generally seems more comfortable.
My only issue is that it is often on back order. Hopefully they will ramp up production quickly so there are no gaps in treatment.
I think this is going to be a wonderful option for our older dogs.
Oh that is WONDERFUL Bonnie I’m so happy for you and Buddy! A 17 year old Golden is AMAAAAAZING! And now that Galliprant is out, I’m sure you’ll be able to get regular supplies. Congrats on finding the keys to keep him happy!
AS ALWAYS, thank np you for.bringing this promising new product to our attention!
To know there is an alternative to NSAIDs with allmst no side effects, or at least none that are life threatening!
Thanks for including the number of dogs in the study, the doeses, length of time, etc. Appears to be a real solod study.
And APPLAUSE to the MAGNIFICENT OAKTOWN PACK for stepping up as our “test models” and for their honest feedback from their own firsthand experience! To hear that the HANDSOME AUSTIN RAY is feelinf perkier a d enjoying his walks more is GREAT news!!
Now, if they decide to make it available for human consumptions, sign me up!! 🙂
Tha js again for the information and tha js to the Oaktown Pack! 🙂
Hey Sally! You are very welcome. And it does appear that it’s being studied for human use, so that would be awesome.
Amazing. This is a true break through. 🙂 Glad it is helping Austin Ray.
I know, it’s terrific isn’t it? I hope your pack doesn’t need it anytime soon but at least it’s there if they ever do.
This is the drug my rehab vet was talking about. Unfortunately, it is not yet licensed for use in Europe, though I understand it may be approved later this year. If it does become available, I will certainly be trying it for both my girls.
Paws & fingers crossed your girls will get to give it a try!